Literature DB >> 11485371

Effects of nitric oxide synthase inhibitors on vascular hyperpermeability with thermal injury in mice.

H Inoue1, K Ando, N Wakisaka, K Matsuzaki , M Aihara, N Kumagai.   

Abstract

The role of nitric oxide and related synthase in thermal injury was investigated by using models of experimental burn to evaluate severity from the aspect of vascular permeability. Thermal injuries were produced in the murine right ear by pinching with a pair of preheated tweezers. Immediately thereafter, Evans blue dye was intravenously administered, and the mice injured with burns were sacrificed at various times. The burned ears were collected and hydrolyzed, and the level of extracted dye was measured as an indicator of inflammation. Vascular hyperpermeability was suppressed by the administration of nitric oxide synthase inhibitors. LNAME not only suppressed vascular hyperpermeability in thermal injuries in a dose-dependent manner but was also effective with either prophylactic or therapeutic administration. Although aminoguanidine also suppressed the inflammatory response, it had no effect on the early inflammatory phase. Nitric oxide synthase is well known to have two types of isozymes. Aminoguanidine, an inhibitor specific to inducible nitric oxide synthase, suppressed the late phase 6 h after injury, suggesting that inducible nitric oxide synthase is involved in inflammatory responses of thermal injuries. These results also demonstrated that inducible nitric oxide synthase-like protein stained the burned region immunohistochemically. Therefore, both types of enzymes mediating nitric oxide affect inflammatory responses, i.e., vascular hyperpermeability, and their regulation may lead to the development of new therapy for thermal injuries. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485371     DOI: 10.1006/niox.2001.0350

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  8 in total

Review 1.  Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.

Authors:  Scott P Nichols; Wesley L Storm; Ahyeon Koh; Mark H Schoenfisch
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 2.  Gammadelta T-cells: potential regulators of the post-burn inflammatory response.

Authors:  Martin G Schwacha
Journal:  Burns       Date:  2008-10-31       Impact factor: 2.744

3.  Gamma delta (γδ) T-cells are critical in the up-regulation of inducible nitric oxide synthase at the burn wound site.

Authors:  Richard F Oppeltz; Meenakshi Rani; Qiong Zhang; Martin G Schwacha
Journal:  Cytokine       Date:  2012-07-23       Impact factor: 3.861

4.  Functional significance of inducible nitric oxide synthase induction and protein nitration in the thermally injured cutaneous microvasculature.

Authors:  Andrew Rawlingson; Khalid Shendi; Stanley A Greenacre; Timothy G England; Andrew M Jenner; Robin N Poston; Barry Halliwell; Susan D Brain
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

Review 5.  Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.

Authors:  Jayme A Farina Junior; Andrea Carla Celotto; Marcelo Felix da Silva; Paulo Roberto B Evora
Journal:  Med Sci Monit       Date:  2012-05

6.  Different expressions of AQP1, AQP4, eNOS, and VEGF proteins in ischemic versus non-ischemic cerebropathy in rats: potential roles of AQP1 and eNOS in hydrocephalic and vasogenic edema formation.

Authors:  Jaehyun Kim; Yongwook Jung
Journal:  Anat Cell Biol       Date:  2011-12-30

7.  Curbing inflammation in burn patients.

Authors:  Jayme A Farina; Marina Junqueira Rosique; Rodrigo G Rosique
Journal:  Int J Inflam       Date:  2013-05-20

8.  Multi-scale optical imaging of the delayed type hypersensitivity reaction attenuated by rapamycin.

Authors:  Meijie Luo; Zhihong Zhang; Hui Li; Sha Qiao; Zheng Liu; Ling Fu; Guanxin Shen; Qingming Luo
Journal:  Theranostics       Date:  2014-01-11       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.